EndoGastric Solutions Completes $30 million Financing Round

Financing to Support Clinical Publications, Reimbursement Initiatives and Research and Development SAN MATEO, Calif. (May 6, 2014)–EndoGastric Solutions® (EGS), the leader in endoluminal reconstructive treatment for gastroesophageal reflux disease (GERD), announced...

EndoGastric Solutions Names Industry Veteran Skip Baldino CEO

Baldino brings nearly three decades of healthcare leadership experience to EGS as it works to advance the field of advanced endoluminal procedural techniques SAN MATEO, Calif. (May 1, 2014)–EndoGastric Solutions® (EGS), the leader in endoluminal reconstructive...